Paclitaxel protein bound (A) plus gemcitabine (G) plus cisplatin (C) and hydroxychloroquine (HCQ) neoadjuvant therapy for localized pancreatic ductal adenocarcinoma (PDAC).

Autor: Borazanci, Erkut Hasan, Jameson, Gayle S., Snyder, Courtney Edwards, Thosani, Amar, Sckolnik, Steven, Korn, Ronald Lee, Rahmanuddin, Syed, Mocan, Dan, Pearse, Shelby, Gordon, Michael S., Von Hoff, Daniel D., Modasi, Aryan, Amini, Albert
Zdroj: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p667-667, 117p
Databáze: Supplemental Index